You just read:

EUSA Pharma Announces 10-Year Outcome Data Demonstrating Utility of PROSTASCINT(R) in Guiding Prostate Cancer Radiotherapy and Improving Disease-Free Survival

News provided by

EUSA Pharma

Nov 03, 2010, 07:46 ET